» Articles » PMID: 10595959

Calcineurin Plays a Critical Role in Pressure Overload-induced Cardiac Hypertrophy

Overview
Journal Circulation
Date 1999 Dec 14
PMID 10595959
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cardiac hypertrophy is a fundamental adaptive response to hemodynamic overload; how mechanical load induces cardiac hypertrophy, however, remains elusive. It was recently reported that activation of a calcium-dependent phosphatase, calcineurin, induces cardiac hypertrophy. In the present study, we examined whether calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy.

Methods And Results: Pressure overload produced by constriction of the abdominal aorta increased the activity of calcineurin in the rat heart and induced cardiac hypertrophy, including reprogramming of gene expression. Treatment of rats with a calcineurin inhibitor, FK506, inhibited the activation of calcineurin and prevented the pressure overload-induced cardiac hypertrophy and fibrosis without change of hemodynamic parameters. Load-induced expression of immediate-early-response genes and fetal genes was also suppressed by the FK506 treatment.

Conclusions: The present results suggest that the calcineurin signaling pathway plays a pivotal role in load-induced cardiac hypertrophy and may pave the way for a novel pharmacological approach to prevent cardiac hypertrophy.

Citing Articles

Transforming growth factor-β and bone morphogenetic protein signaling pathways in pathological cardiac hypertrophy.

Wen J, Liu G, Liu M, Wang H, Wan Y, Yao Z Cell Cycle. 2024; 22(21-22):2467-2484.

PMID: 38179789 PMC: 10802212. DOI: 10.1080/15384101.2023.2293595.


The emerging importance of immunophilins in fibrosis development.

Alqudah A, Abudalo R, Qnais E, Wedyan M, Oqal M, McClements L Mol Cell Biochem. 2022; 478(6):1281-1291.

PMID: 36302992 PMC: 10164022. DOI: 10.1007/s11010-022-04591-1.


Emerging therapeutic targets for cardiac hypertrophy.

Winkle A, Nassal D, Shaheen R, Thomas E, Mohta S, Gratz D Expert Opin Ther Targets. 2022; 26(1):29-40.

PMID: 35076342 PMC: 8885901. DOI: 10.1080/14728222.2022.2031974.


Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?.

Lemay S, Awada C, Shimauchi T, Wu W, Bonnet S, Provencher S Cells. 2021; 10(6).

PMID: 34208388 PMC: 8231250. DOI: 10.3390/cells10061473.


Congestive heart failure model representing aortic banding induced hypertrophy: A study to analyse extent of pressure overload and alteration in myocardial structure and function.

Patel A, Patel D Int J Cardiol Heart Vasc. 2021; 34:100755.

PMID: 33816767 PMC: 8008182. DOI: 10.1016/j.ijcha.2021.100755.